AC Immune SA (FRA:IMR)

AC Immune Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	290	258	447	147	408	324
Market Cap Growth	13.74%	-42.27%	203.06%	-63.84%	25.73%	-40.39%
Enterprise Value	178	81	370	16	233	107
Last Close Price	2.88	2.53	4.30	1.69	4.38	4.21
PS Ratio	62.07	8.86	28.11	37.03	-	22.75
PB Ratio	4.35	2.16	2.59	0.86	1.82	1.63
P/TBV Ratio	22.56	3.91	3.77	1.23	2.33	1.63
P/FCF Ratio	-	3.71	-	-	-	-
P/OCF Ratio	-	3.68	-	-	-	-
EV/Sales Ratio	37.79	2.78	23.28	3.99	-	7.48
EV/FCF Ratio	-3.49	1.16	-	-	-	-
Debt / Equity Ratio	0.08	0.05	0.02	0.02	0.01	0.01
Debt / FCF Ratio	-	0.08	-	-	-	-
Asset Turnover	0.02	0.13	0.08	0.02	-	0.06
Quick Ratio	1.12	1.66	8.72	10.75	9.97	16.25
Current Ratio	1.16	1.71	9.22	11.16	10.12	16.53
Return on Equity (ROE)	-74.63%	-37.31%	-32.91%	-35.29%	-32.63%	-25.38%
Return on Assets (ROA)	-21.96%	-15.82%	-18.18%	-19.79%	-19.74%	-14.23%
Return on Capital (ROIC)	-45.59%	-23.23%	-19.95%	-21.78%	-21.82%	-15.53%
Return on Capital Employed (ROCE)	-99.70%	-40.30%	-31.70%	-40.60%	-32.70%	-27.30%
Earnings Yield	-26.48%	-21.03%	-13.04%	-48.55%	-17.27%	-17.64%
FCF Yield	-17.58%	26.96%	-14.71%	-51.33%	-16.16%	-17.44%
Buyback Yield / Dilution	-4.26%	-17.71%	-1.36%	-11.48%	-4.24%	-1.12%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.